Director, AI Enterprise Process & Innovation salary at AstraZeneca
Total compensation insights for Director, AI Enterprise Process & Innovation roles at AstraZeneca, including base salary, annual bonus, and equity where available.
Typical range: €130.0K – €130.0K
Compensation distribution across percentiles
EUR / yrHow pay varies from entry-to-level offers (25th percentile) to top-of-band packages (75th percentile).
Base salary, equity & bonus breakdown
Compare with other companies
See what peer employers pay for similar roles
About this estimate
This compensation guide for Director, AI Enterprise Process & Innovation at AstraZeneca synthesizes aggregated PayPeek compensation estimates to reflect total annual earnings (base salary, target bonus, and annualized equity).
PayPeek has analyzed 1 related profile estimates with experience at AstraZeneca.
Actual offers vary based on geographic tier, leveling, competing offers, and career tenure. Use the PayPeek browser extension on LinkedIn to calibrate an estimate for a specific person or role level.
Frequently asked questions
What is the salary for a Director, AI Enterprise Process & Innovation at AstraZeneca?
Based on available compensation data, a Director, AI Enterprise Process & Innovation at AstraZeneca typically earns around €130,000 per year in total compensation (€10,833 per month). The middle 50% observed range (25th to 75th percentile) is €130.0K – €130.0K.
Does this include stock and bonus for AstraZeneca?
Yes. Total compensation for Director, AI Enterprise Process & Innovation at AstraZeneca includes base salary, annual bonus, and equity / stock grants where applicable.
How can I estimate my own salary at AstraZeneca?
Install the PayPeek browser extension, open any LinkedIn profile with experience at AstraZeneca, and get an instant compensation estimate tailored to that person's tenure, seniority, and location.
Estimate any LinkedIn profile
See total compensation for yourself or anyone on LinkedIn — tailored to exact tenure, seniority, and career history, not just averages for AstraZeneca.